Table 4 Markers of severity of disease divided by ceiling of care decisions
All patients (n = 409) | Level 1 (n = 208) | Level 2 (n = 75) | Level 3 (n = 126) | p-value | |
|---|---|---|---|---|---|
Laboratory findings | |||||
Hb | 129·2 ± 20·7 | 126·6 ± 21·8 | 125·0 ± 21·6 | 135·9 ± 16·5 | < 0·001 |
WCC | 7·0 (5·4–9·4) | 7·2 (5·4–10·0) | 6·5 (5·0–9·1) | 7·1 (5·6–9·5) | 0·23 |
ANC | 5·4 (4·0–8·0) | 5·7 (4·0–8·9) | 5·1 (3·9–7·8) | 5·6 (4·2–8·3) | 0·38 |
Lymphocyte count | 0·8 (0·5–1·1) | 0·7 (0·5–1·1) | 0·7 (0·5–1·0) | 0·8 (0·6–1·1) | 0·12 |
Na2+ | 138 (136–141) | 140 (136–145) | 137 (135·8–140) | 137 (135–139) | < 0·001 |
K+ | 4·0 (3·7–4·4) | 4·0 (3·7–4·5) | 4·2 (3·7–4·5) | 3·9 (3·7–4·2) | 0·034 |
Creatinine | 81 (63–117) | 95 (68–143) | 86·5 (65·8–129·5) | 74 (60·3–89·8) | < 0·001 |
CRP | 90 (45–169) | 77·5 (34·8–159·8) | 106 (72·3–187·3) | 110 (68–192) | 0·001 |
Ddimer | 467 (258·5–1035·3) | 496 (266–1978) | 671 (387–1042) | 373 (223–924) | 0·068 |
hsTNI | 20·5 (8·1–60) | 40·0 (17·2–94·3) | 25·5 (9·9–70·5) | 8·5 (4·6–22·2) | < 0·001 |
Ferritin | 460 (220–982) | 365 (143·8–671·5) | 510 (261·3–946) | 674 (338·5–1458) | < 0·001 |
Procalcitonin | 0·15 (0·08–0·38) | 0·17 (0·08–0·52) | 0·14 (0·08–0·32) | 0·15 (0·09–0·40) | 0·60 |
Clinical observations | |||||
RR (min−1) | 22 (18–28) | 20 (18–28) | 22·5 (20–28) | 24 (20–29) | 0·026 |
O2 saturations (%) | 94·5 (89–96) | 95 (90–97) | 94 (88–96) | 94 (89–96) | 0·065 |
Heart rate (min−1) | 90 (76–103) | 89 (73–102·8) | 89 (79–101·3) | 96 (86–108·5) | 0·001 |
SBP (mmHg) | 129·2 ± 23·5 | 130·4 ± 25·5 | 131·2 ± 24·4 | 126·2 ± 18·8 | 0·21 |
Temperature (°C) | 37·7 ± 1·1 | 37·4 ± 1·1 | 37·7 ± 1·1 | 38·0 ± 1·0 | < 0·001 |
Chest radiography | |||||
COVID-19 [n(%)] | 190 (47·4) | 61 (29·6) | 40 (55·6) | 89 (72·4) | < 0·001 |
Indeterminate [n(%)] | 125 (31·2) | 79 (38·2) | 22 (30·6) | 24 (19·5) | |
Non-COVID-19 [n(%)] | 86 (21·4) | 66 (32·0) | 10 (13·9) | 10 (8·1) | |